🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether treatment of unexplained ...
Status
Terminated
Location
Lakeview Medical Research
Start Date
2012-03
Trial ID
NCT01506726
To test the preliminary efficacy of 16.0 mg of Prazosin daily versus placeb...
Status
Completed
Location
Yale University School of Medicine: Yale Stress Center
Start Date
2009-09
Trial ID
NCT00585780
Treatments Being Tested
The purpose of this study is to determine whether low dose Asacol® (27 mg/k...
Status
Terminated
Location
Research Site
Start Date
2009-10
Trial ID
NCT01004185
Treatments Being Tested
The aim of the study is to assess the effect of oral probiotics containing ...
Status
Completed
Location
Institute of Dentistry of Sechenov University
Start Date
2023-02-20
Trial ID
NCT05727436
To study the effect of Xyrem (9 g), Xyrem (9 g) plus modafinil 200 mg admin...
Status
Completed
Location
Clinical Research Group of St. Petersburg
Start Date
2003-11
Trial ID
NCT00086281
Treatments Being Tested
Primary Objective: * Investigate the possible role of the CYP2C19 genotype...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-04
Trial ID
NCT01123824
Treatments Being Tested
This study assessed the safety and efficacy of MK-3577. The primary efficac...
Status
Terminated
Location
Multiple Locations
Start Date
2009-03-24
Trial ID
NCT00868790
Treatments Being Tested
When a patient with Parkinson's disease (PD) is initially treated with L-do...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-14
Trial ID
NCT01155466
This study is designed as a randomized, double blind, parallel group, place...
Status
Completed
Location
Study Site
Start Date
2016-11
Trial ID
NCT02949388
Treatments Being Tested
To compare the efficacy and safety of aliskiren in combination with losarta...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-10
Trial ID
NCT00219141
Treatments Being Tested